Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 30Active not recruiting 11Terminated 6Unknown 5Recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 9Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Triple Negative Breast Neoplasms 1Neoplasms, Plasma Cell 1Malignant Plasma Cell Neoplasms 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Plasma Cell 1Infections 1Epstein-Barr Virus Infections 1

Interventions

fludarabine 2Dexamethasone 2Cyclophosphamide 2pomalidomide 1isatuximab 1daratumumab 1Therapeutics 1Sirolimus 1Prednisone 1Lenalidomide 1Lead 1Everolimus 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms, Plasma Cell × Lenalidomide × Clear all
NCT07600151 2026-05-20

CONQUISTADOR

Universitätsklinikum Hamburg-Eppendorf

Phase 1/2 Not yet recruiting
220 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡